Name: Nasus Pharma Ltd. (NSRX) Cash Flow Statement
Creator: FinSpry

Nasus Pharma Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scale:

Scroll to see more

Cash flow statement showing operating, investing, and financing activities for Nasus Pharma Ltd. (NSRX) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022
Period Ending	Dec 2024	Dec 2023	Dec 2022
Operating Activities
Net Income	-1.53	-1.05	-1.71
Stock Based Compensation	0.01	0.04	0.02
Change in Working Capital	0.41	0.17	0.48
Change in Accounts Payable	0.00	-0.12	0.15
Change in Other Working Capital	0.03	0.28	0.33
Other Operating Activities	0.03	0.08	-0.41
Net Cash from Operating Activities	-0.67	-1.03	-1.21
Investing Activities
Other Investing Activities	0.00	0.00	-0.16
Net Cash from Investing Activities	0.00	0.00	-0.16
Financing Activities
Common Stock Issued	1.00	1.00	0.97
Other Financing Activities	-0.23	0.00	-0.23
Net Cash from Financing Activities	0.77	1.06	1.24
Summary
Effect of Forex Changes on Cash	0.00	0.01	-0.01
Net Change in Cash	0.11	0.04	-0.14
Cash at Beginning of Period	0.21	0.17	0.31
Cash at End of Period	0.31	0.21	0.17
Free Cash Flow	-0.67	-1.03	-1.21